By: Kairos Ventures On: August 18, 2020 In: Foldax, Portfolio News

Foldax® announced that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition...

Read more
By: Kairos Ventures On: June 22, 2020 In: Foldax, Portfolio News

Heart valve innovator Foldax®, a company reinventing every aspect of the heart valve, from material to design to manufacturing,...

Read more
By: Kairos Ventures On: June 2, 2020 In: Foldax, Portfolio News

Foldax Tria™ LifePolymer™ heart valve technology wins “Medical Device Engineering Breakthrough Award” in the fourth annual MedTech Breakthrough Awards...

Read more
By: Kairos Ventures On: September 23, 2019 In: Foldax, Portfolio News

Foldax, Inc. announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for...

Read more
By: Kairos Ventures On: February 27, 2019 In: Foldax, Portfolio News

Kairos Ventures portfolio company Foldax Inc. announced the U.S. Food and Drug Administration (FDA) has granted investigative device exemption...

Read more
By: Kairos Ventures On: August 31, 2015 In: Foldax, Portfolio News

We are excited to announce that Foldax is the latest company to join our portfolio, following our investment in...

Read more